The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zimmer Biomet Holdings, Inc
F:ZIM
|
US |
|
Amadeus IT Group SA
F:AI3A
|
ES |
|
Y
|
Yum! Brands Inc
XMUN:TGR
|
US |
|
Nel ASA
F:D7G
|
NO |
|
Kyowa Electronic Instruments Co Ltd
TSE:6853
|
JP |
|
Pirelli and C. S.p.a
MIL:PIRC
|
IT |
|
i-mobile Co Ltd
TSE:6535
|
JP |
|
Hannan Metals Ltd
XTSX:HAN
|
CA |
|
M
|
ManpowerGroup Inc
F:MPW
|
US |
|
Science Group PLC
LSE:SAG
|
UK |
|
V
|
VF Corp
F:VFP
|
US |
|
A
|
Avaland Bhd
KLSE:AVALAND
|
MY |
|
Skane mollan AB
STO:SKMO
|
SE |
|
Adveritas Ltd
F:4TM
|
AU |
|
Nishio Holdings Co Ltd
TSE:9699
|
JP |
|
Agillic A/S
CSE:AGILC
|
DK |
|
V
|
Valneva SE
XMUN:AYJ
|
FR |
|
G
|
Golden Ridge Resources Ltd
F:44GG
|
CA |
|
B
|
Burckhardt Compression Holding AG
XMUN:B5H
|
CH |
|
F
|
Frequency Electronics Inc
F:98K
|
US |
|
Zespol Elektrocieplowni Wroclawskich Kogeneracja SA
F:2ZO
|
PL |
|
Healios KK
TSE:4593
|
JP |
|
D
|
Digital Turbine Inc
F:4MD
|
US |
|
Schindler Holding AG
SIX:SCHP
|
CH |
Zimmer Biomet Holdings, Inc (ZIM)’s 12-month stock price forecast through October 2027 has a consensus target of €100.19, implying 16% upside. The forecast is based on price targets from 26 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
ZIM is 100.19 EUR with a low forecast of 87.87 EUR and a high forecast of 127.05 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 7 years is 4%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 7 years is 5%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 7 years is 12%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 38%.
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 7 years is 19%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more